Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million

2018-11-27

Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

2018-10-15

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares
Boston Pharmaceuticals

2018-10-03

Boston Pharmaceuticals Acquires Three Novel Anti-Infective Programs from Novartis
Dr. Sophie Kornowski

2018-06-26

Gurnet Point Capital Appoints Dr. Sophie Kornowski as Senior Partner
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals

2017-08-30

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors
Innocoll

2017-07-25

Gurnet Point L.P. Completes Acquisition of Innocoll Holdings plc
Type 1 collagen

2017-04-05

Gurnet Point L.P. enters into agreement to acquire Innocoll Holdings plc
crossover investment

2016-12-07

Gurnet Point Invests $92M in Primary Care Innovator Crossover Health
Food allergies

2016-11-15

Gurnet Point Capital Invests in BEFORE Brands
boston pharma

2015-11-19

Gurnet Point Capital launches new drug development company, Boston Pharmaceuticals